Table 3

Characteristics of the patient cohort at baseline including the diagnosis and details of conventional treatment

PatientSexAgeDiagnosisConventional treatment at baseline
1M53RosaceaLiquifilm, Viscotears, Oc Lacrilube
2M61Keratoconjunctivitis siccaLiquifilm, Oc Simple Eye
3M46Graft versus host diseaseLiquifilm, Viscotears, Ilube
4F71Sjögren’s syndrome Behçet’s syndromeViscotears, Oc Simple Eye, Clobetasone Hypotears
5F30Riley-Day syndromeViscotears, Chloramphenicol
6M59Dry eyeSnotears, Oc Simple Eye
7F37Sjögren’s syndromeVital Eyes
8M58IgA ocular cicatrical pemphigoidLacrilube, Acetylcysteine, Retinoic acid, Hyaluronate Predsol
9F28Blepharitis + dry eyeDoxycycline, Viscotears, Oc Betnesol
10M53Keratoconjunctivitis siccaLiquifilm, Doxycycline, Fucthalmic, Oc Hydrocortisone
11F41Sjögren’s syndromeDoxycycline, normal saline, Betnesol
12F60Sjögren’s syndromeHypromellose, Lacrilube, Hyaluronate
13F67Sjögren’s syndromeLiquifilm, Lacrilube
14F53Dry eye, congenital glaucomaViscotears, Betagan
15F49Sjögren’s syndromeHypromellose, Lacrilube
16M69Keratoconjunctivitis siccaHealanoid, Liquifilm, Lacrilube, Salagen